Log on / register
Feedback | Support | My details
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial.
Escudier B, Dorval T, Chaput N, André F, Caby MP, Novault S, Flament C, Leboulaire C, Borg C, Amigorena S, Boccaccio C, Bonnerot C, Dhellin O, Movassagh M, Piperno S, Robert C, Serra V, Valente N, Le Pecq JB, Spatz A, Lantz O, Tursz T, Angevin E, Zitvogel L
J Transl Med 2005 Mar 2, 3:10
[Full text] [PubMed] [Related articles]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Different types of in vitro generated human monocyte-derived dendritic cells release exosomes with distinct phenotypes.
Johansson SM, Admyre C, Scheynius A, Gabrielsson S
Immunology 2008 Apr, 123:491-9
[PubMed Central] [PubMed] [Related articles]

2.
Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha.
Viaud S, Terme M, Flament C, Taieb J, André F, Novault S, Escudier B, Robert C, Caillat-Zucman S, Tursz T, Zitvogel L, Chaput N
PLoS One 2009, 4:e4942
[PubMed Central] [PubMed] [Related articles]

3.
Exosome nanovesicles displaying G protein-coupled receptors for drug discovery.
Estelles A, Sperinde J, Roulon T, Aguilar B, Bonner C, LePecq JB, Delcayre A
Int J Nanomedicine 2007, 2:751-60
[PubMed Central] [PubMed] [Related articles]

printer friendly 
to  [Help]

© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.